The negative regulation of JAK2 activity by LNK is crucial, as shown by faster development of MPN in LNK−/− mice expressing a mutated JAK2, and by the description of cases of MPN associated with LNK mutations in humans.64, 65. This evidence concerns the gene JAK2 and myeloproliferative neoplasm.